126 related articles for article (PubMed ID: 12821360)
21. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Rose PG; Blessing JA; Arseneau J
Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of vinblastine in previously treated squamous carcinoma of the cervix. A Gynecologic Oncology Group study.
Sutton GP; Blessing JA; Barnes W; Ball H
Am J Clin Oncol; 1990 Dec; 13(6):470-1. PubMed ID: 2239800
[TBL] [Abstract][Full Text] [Related]
23. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
McGuire WP; Blessing JA; Yordan E; Beecham J
Invest New Drugs; 1989 Jul; 7(2-3):235-8. PubMed ID: 2793379
[TBL] [Abstract][Full Text] [Related]
24. Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: a Kansai Clinical Oncology Group study.
Takekuma M; Hirashima Y; Ito K; Tsubamoto H; Tabata T; Arakawa A; Itani Y; Furukawa N; Murakoshi H; Takeuchi S
Gynecol Oncol; 2012 Sep; 126(3):341-5. PubMed ID: 22609108
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Morris M; Blessing JA; Monk BJ; McGehee R; Moore DH
J Clin Oncol; 2004 Aug; 22(16):3340-4. PubMed ID: 15310778
[TBL] [Abstract][Full Text] [Related]
26. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.
Look KY; Blessing JA; Levenback C; Kohler M; Chafe W; Roman LD
Gynecol Oncol; 1998 Sep; 70(3):334-8. PubMed ID: 9790784
[TBL] [Abstract][Full Text] [Related]
27. A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group Study.
Plaxe SC; Blessing JA; Lucci JA; Hurteau JA
Invest New Drugs; 2001; 19(1):77-80. PubMed ID: 11291835
[TBL] [Abstract][Full Text] [Related]
28. A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus.
Wang J; Chang J; Yu H; Wu X; Wang H; Li W; Ji D; Peng W
Cancer Chemother Pharmacol; 2013 Apr; 71(4):905-11. PubMed ID: 23370661
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix: a Gynecological Oncology Group study.
Lincoln S; Blessing JA; McGehee R; Lentz SS
Am J Clin Oncol; 1997 Feb; 20(1):84-5. PubMed ID: 9020296
[TBL] [Abstract][Full Text] [Related]
30. A phase II study of weekly docetaxel for patients with advanced or recurrent cancer of the cervix.
Pearl ML; Johnston CM; McMeekin DS
Gynecol Obstet Invest; 2007; 64(4):193-8. PubMed ID: 17664880
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study.
Wagenaar HC; Pecorelli S; Mangioni C; van der Burg ME; Rotmensz N; Anastasopoulou A; Zola P; Veenhof CH; Lacave AJ; Neijt JP; van Oosterom AT; Einhorn N; Vermorken JB
Eur J Cancer; 2001 Sep; 37(13):1624-8. PubMed ID: 11527687
[TBL] [Abstract][Full Text] [Related]
32. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Gershenson DM; McGehee R
J Clin Oncol; 1999 Sep; 17(9):2676-80. PubMed ID: 10561341
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of fazarabine (NSC 281272) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Manetta A; Blessing JA; Mann WJ; Smith DM
Am J Clin Oncol; 1995 Oct; 18(5):439-40. PubMed ID: 7572764
[TBL] [Abstract][Full Text] [Related]
34. A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: a Gynecologic Oncology Group study.
Jacobs AJ; Blessing JA; Munoz A
Gynecol Oncol; 1992 Mar; 44(3):268-70. PubMed ID: 1541440
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B
Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
[TBL] [Abstract][Full Text] [Related]
36. [Phase II study of carboplatin in cervical carcinoma].
Noda K; Kato T; Ikeda M; Akiya K; Yajima A; Ueda G; Nishiya I; Takamizawa H; Terashima Y; Tsutsui F
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3067-72. PubMed ID: 3056277
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.
Sutton GP; Blessing JA; McGuire WP; Patton T; Look KY
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):805-7. PubMed ID: 8456884
[TBL] [Abstract][Full Text] [Related]
38. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
Mori T; Makino H; Okubo T; Fujiwara Y; Sawada M; Kuroboshi H; Tsubamoto H; Murakoshi H; Motohashi T; Kitawaki J; Ito K
J Obstet Gynaecol Res; 2019 Mar; 45(3):671-678. PubMed ID: 30575239
[TBL] [Abstract][Full Text] [Related]
39. A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
Feun LG; Blessing JA; Barrett RJ; Hanjani P
Am J Clin Oncol; 1993 Dec; 16(6):506-8. PubMed ID: 8256767
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
Muggia FM; Blessing JA; McGehee R; Monk BJ
Gynecol Oncol; 2004 Aug; 94(2):483-7. PubMed ID: 15297192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
